Skip to main content
. 2022 Feb 10;2022(2):CD013405. doi: 10.1002/14651858.CD013405.pub2

Wang 2019.

Study characteristics
Methods RCT; parallel design
Review comparison group: PFNA vs DHS
Participants Total number of randomised participants: 114
Inclusion criteria: diagnosed with intertrochanteric fractures on X‐ray; no cardiac accidents before admission; no cognitive disorder; preoperative BP and blood sugar (and other common diseases) controlled in a normal state
Exclusion criteria: severe cardiovascular and cerebrovascular disease; combined with other fractures; pathological fracture; mental illness before fracture; surgical contraindications
Setting: hospital; single centre; China
Baseline characteristics (overall)
  • Age, mean (SD): 73.16 (± 3.47) years

  • Gender, M/F: 43/71

  • Comorbidities, type, n: 50 had hypertension; 41 had diabetes

  • Preoperative waiting time, mean (SD): 4.18 (± 0.72) days

  • Fracture classification, n: Evans‐Jensen type 1: 33; type II: 32; type III: 32, and type IV: 8. All closed fractures


Note:
  • study authors reported only overall baseline characteristics. No data reported for: smoking history, medication, BMI, mobility assessment, place of residence; cognitive status, ASA status

Interventions General details: all given antibiotics; epidural anaesthesia; on POD2, allowed to sit, half‐squat, sit up, turn over, and perform contractile functional exercises of active and passive muscle, as well as knee flexion and extension exercises
Intervention group 1:
  • PFNA; proximal locking was performed using a spiral blade which was locked statically; distal locking was performed through an aiming arm. Although the study report did not specifically report the length of nails, it is highly probable that all were short nails.

  • Randomised = 57


Intervention group 2:
  • DHS

  • Randomised = 57

Outcomes Outcomes measured/reported by study authors: operation time; volume of intraoperative blood loss; postoperative drainage volume; time to weight bearing; serum inflammatory markers; serum levels of MI markers and heart failure markers
Outcomes relevant to the review: none
Notes Funding/sponsor/declarations of interest: not reported
Study dates: January 2016 to February 2018
Note:
  • we did not conduct risk of bias assessment because study reported no review‐relevant outcomes.